Related Experiment Videos
[Ketamine lollipop for pediatric premedication]
T Horiuchi1, K Kurehara, K Kitaguchi
1Department of Anesthesiology, Nara Medical University, Kashihara 634-8521.
Insights
Ketamine lollipop (50 mg) shows promise for pediatric premedication, maintaining good emotional states and avoiding side effects in young patients. This novel formulation offers a potentially effective and well-tolerated option for children undergoing medical procedures.
Area of Science:
- Anesthesiology
- Pediatric Medicine
- Pharmacology
Context:
- Premedication in pediatric patients is crucial for managing anxiety and ensuring cooperation during medical procedures.
- Traditional premedication methods can have drawbacks, necessitating the exploration of novel delivery systems.
- Ketamine is an anesthetic agent with sedative and anxiolytic properties.
Purpose:
- To evaluate the efficacy and safety of a 50 mg ketamine lollipop as a premedication agent in pediatric patients.
- To assess the emotional state and presence of side effects in children receiving ketamine lollipop premedication.
- To determine the potential of ketamine lollipop as a viable alternative for pediatric premedication.
Summary:
- A study involving 12 pediatric patients (aged 1 year 7 months to 6 years) administered a 50 mg ketamine lollipop for premedication.
- Patients exhibited a generally good emotional state post-administration.
- No typical adverse side effects associated with ketamine were observed in the study group.
Impact:
- The ketamine lollipop formulation demonstrates a favorable safety profile and tolerability in young children.
- Results suggest that ketamine lollipop is a promising option for premedication in pediatric settings.
- This novel delivery method could improve the patient experience and procedural outcomes for pediatric medical interventions.
Abstract:
Lollipop containing ketamine (50 mg) was evaluated for the premedication of pediatric patients. The subject of this study were 12 children aged from 1 year 7 months to 6 years. They received the lollipop and showed relatively good emotional state and no typical side effects. These results suggest good possibility of ketamine lollipop as the premedication for pediatric patients.